Literature DB >> 17060971

EGF receptors as a target for cancer therapy.

John Mendelsohn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 17060971      PMCID： PMC2263769     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  4 in total

Review 1.  Blockade of receptors for growth factors: an anticancer therapy--the fourth annual Joseph H Burchenal American Association of Cancer Research Clinical Research Award Lecture.

Authors:  J Mendelsohn
Journal:  Clin Cancer Res       Date:  2000-03       Impact factor: 12.531

Review 2.  Targeting the epidermal growth factor receptor for cancer therapy.

Authors:  John Mendelsohn
Journal:  J Clin Oncol       Date:  2002-09-15       Impact factor: 44.544

Review 3.  IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer.

Authors:  R S Herbst; E S Kim; P M Harari
Journal:  Expert Opin Biol Ther       Date:  2001-07       Impact factor: 4.388

Review 4.  Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer.

Authors:  John Mendelsohn; Jose Baselga
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544
  4 in total
  3 in total

Review 1.  Defining the cancer master switch.

Authors:  Courtney J Balentine; David H Berger; Shi-He Liu; Changyi Chen; John Nemunaitis; F Charles Brunicardi
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

2.  Proliferation and migration of tumor cells in tapered channels.

Authors:  Yuan Wan; Deepika Tamuly; Peter B Allen; Young-Tae Kim; Robert Bachoo; Andrew D Ellington; Samir M Iqbal
Journal:  Biomed Microdevices       Date:  2013-08       Impact factor: 2.838

Review 3.  Sweet dreams: How mini-invasive surgery tackles obstructive sleep apnea.

Authors:  Sophia Julia Häfner
Journal:  Biomed J       Date:  2019-05-20       Impact factor: 4.910
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.